Replacing RCTs with real world data for regulatory decision making: a self-fulfilling prophecy?

Abstract

Real world data are advocated as an alternative approach to RCTs for closing knowledge gaps on drugs, but <b>Beate Wieseler and colleagues</b> argue that this approach is the wrong remedy for current challenges in drug development